BRCA2 and breast cancer: The methylation profiles of the promoter regions of tumor suppressor genes such as PTEN and BRCA2 were examined in different types of BC, and many current studies suggest that a few specific cytosine–phosphate–guanine (CpG) sites might be sufficient to provide prognostic information on BC with high accuracy and specificity [14,15].